Wells Fargo lowers Pfizer (NYSE:PFE) price target from $39 to $35

By / / Pfizer

Wells Fargo analyst Mohit Bansal maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $39 to $35.